BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang SE, Hsieh MT, Tsai TH, Hsu SL. Down-modulation of Bcl-XL, release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells. Biochem Pharmacol. 2002;63:1641-1651. [PMID: 12007567 DOI: 10.1016/s0006-2952(02)00894-8] [Cited by in Crossref: 105] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Khatoon F, Ali S, Kumar V, Elasbali AM, Alhassan HH, Alharethi SH, Islam A, Hassan MI. Pharmacological features, health benefits and clinical implications of honokiol. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2120541] [Reference Citation Analysis]
2 Hao R, Ge J, Li M, Song X, Jiang Y, Li F, Sun‐waterhouse D, Li D. Caffeic acid phenethyl ester mitigates cadmium‐induced damage via the Hsa_circ_0010039/miR‐661/Caspase9 axis–mediated apoptosis. Food Frontiers 2021;2:537-46. [DOI: 10.1002/fft2.95] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ong CP, Lee WL, Tang YQ, Yap WH. Honokiol: A Review of Its Anticancer Potential and Mechanisms. Cancers (Basel) 2019;12:E48. [PMID: 31877856 DOI: 10.3390/cancers12010048] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 10.7] [Reference Citation Analysis]
4 Shi X, Du R, Zhang J, Lei Y, Guo H. Evaluation of the anti-cancer potential of Cedrus deodara total lignans by inducing apoptosis of A549 cells. BMC Complement Altern Med 2019;19:281. [PMID: 31651320 DOI: 10.1186/s12906-019-2682-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
5 Jiang WJ, Yao XR, Zhao YH, Gao QS, Jin QG, Li YH, Yan AG, Xu YN. L-carnitine prevents bovine oocyte aging and promotes subsequent embryonic development. J Reprod Dev 2019;65:499-506. [PMID: 31474647 DOI: 10.1262/jrd.2019-046] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
6 Avtanski D, Poretsky L. Phyto-polyphenols as potential inhibitors of breast cancer metastasis. Mol Med 2018;24:29. [PMID: 30134816 DOI: 10.1186/s10020-018-0032-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
7 Yang J, Pei H, Luo H, Fu A, Yang H, Hu J, Zhao C, Chai L, Chen X, Shao X, Wang C, Wu W, Wan L, Ye H, Qiu Q, Peng A, Wei Y, Yang L, Chen L. Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways. Oncotarget 2017;8:915-32. [PMID: 27906672 DOI: 10.18632/oncotarget.13687] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
8 Huang K, Chen Y, Zhang R, Wu Y, Ma Y, Fang X, Shen S. Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo. Cell Death Dis 2018;9:157. [PMID: 29410403 DOI: 10.1038/s41419-017-0166-5] [Cited by in Crossref: 50] [Cited by in F6Publishing: 72] [Article Influence: 12.5] [Reference Citation Analysis]
9 Huang KJ, Kuo CH, Chen SH, Lin CY, Lee YR. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy. J Cell Mol Med 2018;22:1894-908. [PMID: 29363886 DOI: 10.1111/jcmm.13474] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
10 Suvarna V, Murahari M, Khan T, Chaubey P, Sangave P. Phytochemicals and PI3K Inhibitors in Cancer-An Insight. Front Pharmacol 2017;8:916. [PMID: 29311925 DOI: 10.3389/fphar.2017.00916] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
11 Pearson HE, Iida M, Orbuch RA, McDaniel NK, Nickel KP, Kimple RJ, Arbiser JL, Wheeler DL. Overcoming Resistance to Cetuximab with Honokiol, A Small-Molecule Polyphenol. Mol Cancer Ther 2018;17:204-14. [PMID: 29054984 DOI: 10.1158/1535-7163.MCT-17-0384] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
12 Poivre M, Duez P. Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents. J Zhejiang Univ Sci B 2017;18:194-214. [PMID: 28271656 DOI: 10.1631/jzus.B1600299] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 6.6] [Reference Citation Analysis]
13 Godugu C, Doddapaneni R, Singh M. Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC). Colloids Surf B Biointerfaces 2017;153:208-19. [PMID: 28249200 DOI: 10.1016/j.colsurfb.2017.01.038] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
14 Mędra A, Witkowska M, Majchrzak A, Cebula-Obrzut B, Bonner MY, Robak T, Arbiser JL, Smolewski P. Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies. Molecules 2016;21:E995. [PMID: 27483232 DOI: 10.3390/molecules21080995] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
15 Wang Y, Yu RY, He QY. Proteomic Analysis of Anticancer TCMs Targeted at Mitochondria. Evid Based Complement Alternat Med 2015;2015:539260. [PMID: 26568766 DOI: 10.1155/2015/539260] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
16 Avtanski DB, Nagalingam A, Bonner MY, Arbiser JL, Saxena NK, Sharma D. Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis. Mol Oncol 2014;8:565-80. [PMID: 24508063 DOI: 10.1016/j.molonc.2014.01.004] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 8.3] [Reference Citation Analysis]
17 Hua H, Chen W, Shen L, Sheng Q, Teng L. Honokiol augments the anti-cancer effects of oxaliplatin in colon cancer cells. Acta Biochim Biophys Sin (Shanghai) 2013;45:773-9. [PMID: 23786838 DOI: 10.1093/abbs/gmt071] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
18 Lee NJ, Oh JH, Ban JO, Shim JH, Lee HP, Jung JK, Ahn BW, Yoon DY, Han SB, Ham YW, Hong JT. 4-O-methylhonokiol, a PPARγ agonist, inhibits prostate tumour growth: p21-mediated suppression of NF-κB activity. Br J Pharmacol 2013;168:1133-45. [PMID: 23043610 DOI: 10.1111/j.1476-5381.2012.02235.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
19 Webster TJ, Stout DA, Kalmodia S, Basu B. EXPERIMENTAL METHODS AND IN VITRO CYTOXICITY AND GENOTOXICITY OF NANOMATERIALS. Nano LIFE 2013;03:1340008. [DOI: 10.1142/s1793984413400084] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
20 Lin JM, Prakasha Gowda AS, Sharma AK, Amin S. In vitro growth inhibition of human cancer cells by novel honokiol analogs. Bioorg Med Chem 2012;20:3202-11. [PMID: 22533983 DOI: 10.1016/j.bmc.2012.03.062] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
21 Cheng N, Xia T, Han Y, He QJ, Zhao R, Ma JR. Synergistic antitumor effects of liposomal honokiol combined with cisplatin in colon cancer models. Oncol Lett 2011;2:957-62. [PMID: 22866157 DOI: 10.3892/ol.2011.350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 0.2] [Reference Citation Analysis]
22 Arora S, Bhardwaj A, Srivastava SK, Singh S, McClellan S, Wang B, Singh AP. Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells. PLoS One 2011;6:e21573. [PMID: 21720559 DOI: 10.1371/journal.pone.0021573] [Cited by in Crossref: 97] [Cited by in F6Publishing: 86] [Article Influence: 8.8] [Reference Citation Analysis]
23 Wang X, Duan X, Yang G, Zhang X, Deng L, Zheng H, Deng C, Wen J, Wang N, Peng C, Zhao X, Wei Y, Chen L. Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model. PLoS One 2011;6:e18490. [PMID: 21559510 DOI: 10.1371/journal.pone.0018490] [Cited by in Crossref: 86] [Cited by in F6Publishing: 83] [Article Influence: 7.8] [Reference Citation Analysis]
24 Chen G, Wang F, Trachootham D, Huang P. Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds. Mitochondrion 2010;10:614-25. [PMID: 20713185 DOI: 10.1016/j.mito.2010.08.001] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 5.3] [Reference Citation Analysis]
25 Hu J, Chen LJ, Liu L, Chen X, Chen PL, Yang G, Hou WL, Tang MH, Zhang F, Wang XH. Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity. Exp Mol Med. 2008;40:617-628. [PMID: 19116447 DOI: 10.3858/emm.2008.40.6.617] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
26 Raja SM, Chen S, Yue P, Acker TM, Lefkove B, Arbiser JL, Khuri FR, Sun SY. The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis. Mol Cancer Ther 2008;7:2212-23. [PMID: 18645030 DOI: 10.1158/1535-7163.MCT-07-2409] [Cited by in Crossref: 39] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
27 Jiang QQ, Fan LY, Yang GL, Guo WH, Hou WL, Chen LJ, Wei YQ. Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model. BMC Cancer 2008;8:242. [PMID: 18706101 DOI: 10.1186/1471-2407-8-242] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 4.1] [Reference Citation Analysis]
28 Ishitsuka K, Hideshima T, Hamasaki M, Raje N, Kumar S, Hideshima H, Shiraishi N, Yasui H, Roccaro AM, Richardson P, Podar K, Le Gouill S, Chauhan D, Tamura K, Arbiser J, Anderson KC. Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis. Blood 2005;106:1794-800. [PMID: 15870175 DOI: 10.1182/blood-2005-01-0346] [Cited by in Crossref: 138] [Cited by in F6Publishing: 121] [Article Influence: 8.1] [Reference Citation Analysis]
29 Chen F, Wang T, Wu YF, Gu Y, Xu XL, Zheng S, Hu X. Honokiol: A potent chemotherapy candidate for human colorectal carcinoma. World J Gastroenterol 2004; 10(23): 3459-3463 [PMID: 15526365 DOI: 10.3748/wjg.v10.i23.3459] [Cited by in CrossRef: 98] [Cited by in F6Publishing: 88] [Article Influence: 5.4] [Reference Citation Analysis]
30 Wang T, Chen F, Chen Z, Wu YF, Xu XL, Zheng S, Hu X. Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. World J Gastroenterol 2004; 10(15): 2205-2208 [PMID: 15259066 DOI: 10.3748/wjg.v10.i15.2205] [Cited by in CrossRef: 94] [Cited by in F6Publishing: 76] [Article Influence: 5.2] [Reference Citation Analysis]